Success Metrics

Completion Rate
0%(0/1)
Active Trials
2(40%)
Terminated
1(20%)

Phase Distribution

Ph not_applicable
3
60%

Phase Distribution

0

Early Stage

0

Mid Stage

0

Late Stage

Phase Distribution3 total trials
N/ANon-phased studies
3(100.0%)

Highest Phase Reached

Unknown

Trial Status & Enrollment

Completion Rate

0.0%

0 of 2 finished

Non-Completion Rate

100.0%

2 ended early

Currently Active

2

trials recruiting

Total Trials

5

all time

Status Distribution
Active(3)
Terminated(2)

Detailed Status

Recruiting2
Not yet recruiting1
Terminated1
Withdrawn1

Development Timeline

Analytics

Development Status

Total Trials
5
Active
2
Success Rate
0.0%
Most Advanced
N/A

Trials by Phase

N/A3 (100.0%)

Trials by Status

recruiting240%
not_yet_recruiting120%
terminated120%
withdrawn120%

Recent Activity

2 active trials
Showing 5 of 5
not_yet_recruitingnot_applicable

Evaluating the Effect of Nicotine on Eye Movements and Related Behaviors in Electronic Cigarette Users, NICS-EYES Trial

NCT07604246
terminatednot_applicable

Effects of Tobacco Flavoring and Liquid Composition on Vaping Topography

NCT05876091
recruitingnot_applicable

A Comprehensive Evaluation of Tobacco-Flavored vs. Non-Tobacco Flavored E-cigarettes on Smoking Behavior

NCT06260683
recruiting

Vaping Adverse Lung and Heart Events Cohort

NCT06291597
withdrawn

Vaping-Related Seizures - A Prospective Study

NCT06006442

Clinical Trials (5)

Showing 5 of 5 trials
NCT07604246Not Applicable

Evaluating the Effect of Nicotine on Eye Movements and Related Behaviors in Electronic Cigarette Users, NICS-EYES Trial

Not Yet Recruiting
NCT05876091Not Applicable

Effects of Tobacco Flavoring and Liquid Composition on Vaping Topography

Terminated
NCT06260683Not Applicable

A Comprehensive Evaluation of Tobacco-Flavored vs. Non-Tobacco Flavored E-cigarettes on Smoking Behavior

Recruiting
NCT06291597

Vaping Adverse Lung and Heart Events Cohort

Recruiting
NCT06006442

Vaping-Related Seizures - A Prospective Study

Withdrawn

All 5 trials loaded

Drug Details

Intervention Type
OTHER
Total Trials
5